The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
The microbiota in cirrhosis and its role in hepatic decompensation
Open accessAbstract
Cirrhosis - the common end-stage of chronic liver disease - is associated with a cascade of events, of which intestinal bacterial overgrowth and dysbiosis are central. Bacterial toxins entering the portal or systemic circulation can directly cause hepatocyte death, while dysbiosis also affects gut barrier function and increases bacterial translocation, leading to infections, systemic inflammation and vasodilation, which contribute to acute decompensation and organ failure. Acute decompensation and its severe forms, pre-acute-on-chronic liver failure (ACLF) and ACLF, are characterised by sudden organ dysfunction (and failure) and high short-term mortality. Patients with pre-ACLF and ACLF present with high-grade systemic inflammation, usually precipitated by proven bacterial infection and/or severe alcoholic hepatitis. However, no precipitant is identified in 30% of these patients, in whom bacterial translocation from the gut microbiota is assumed to be responsible for systemic inflammation and decompensation. Different microbiota profiles may influence the rate of decompensation and thereby outcome in these patients. Thus, targeting the microbiota is a promising strategy for the prevention and treatment of acute decompensation, pre-ACLF and ACLF. Approaches include the use of antibiotics such as rifaximin, faecal microbial transplantation and enterosorbents (e.g. Yaq-001), which bind microbial factors without exerting a direct effect on bacterial growth kinetics. This review focuses on the role of microbiota in decompensation and strategies targeting microbiota to prevent acute decompensation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Moreau, R., Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.042 · Cited by 3,020
Self-citationMechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Alterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Peng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056
Self-citationExtensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Self-citationPark, J., Kim, M., Kang, S. G., Jannasch, A. H., Cooper, B., Patterson, J., & Kim, C. H. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.44 · Cited by 1,307
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Albillos, A., Lario, M., & Álvarez-Mon, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.010 · Cited by 1,242
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., Noble, N. A., Unser, A. B., Daita, K., Fisher, A. R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.019 · Cited by 1,099
Self-citationCharacterization of fecal microbial communities in patients with liver cirrhosis
Chen, Y., Yang, F., Lu, H., Wang, B., Chen, Y., Lei, D., Wang, Y., Zhu, B., & Li, L. (2011) · Hepatology · doi:10.1002/hep.24423 · Cited by 1,038
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971
Self-citationAntibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances
Francino, M. P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01543 · Cited by 945
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
Duan, Y., Llorente, C., Lang, S., Brandl, K., Chu, H., Jiang, L., White, R. C., Clarke, T. H., Nguyen, K., Torralba, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1742-x · Cited by 844
Self-citationPathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M., & Geuking, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 805
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Kakiyama, G., Pandak, W. M., Gillevet, P. M., Hylemon, P. B., Heuman, D. M., Daita, K., Takei, H., Muto, A., Nittono, H., Ridlon, J. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.003 · Cited by 781
Self-citationClària, J., Stauber, R. E., Coenraad, M. J., Moreau, R., Jalan, R., Pavesi, M., Amorós, À., Titos, E., Alcaraz‐Quiles, J., Oettl, K., et al. (2016) · Hepatology · doi:10.1002/hep.28740 · Cited by 763
Self-citationAlcohol, liver disease and the gut microbiota
Bajaj, J. S. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0099-1 · Cited by 697
Self-citationPonziani, F. R., Bhoori, S., Castelli, C., Putignani, L., Rivoltini, L., Del Chierico, F., Sanguinetti, M., Morelli, D., Paroni Sterbini, F., Petito, V., et al. (2019) · Hepatology · doi:10.1002/hep.30036 · Cited by 654
Acute-on-Chronic Liver Failure
Arroyo, V., Moreau, R., & Jalan, R. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1914900 · Cited by 650
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E. A., Liu, E., Cox, I. J., Kheradman, R., Heuman, D., Wang, J., Gurry, T., et al. (2017) · Hepatology · doi:10.1002/hep.29306 · Cited by 633
Self-citationBernardi, M., Moreau, R., Angeli, P., Schnabl, B., & Arroyo, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.004 · Cited by 632
Self-citationFernández, J., Acevedo, J., Wiest, R., Gustot, T., Amoros, A., Deulofeu, C., Reverter, E., Martínez, J., Saliba, F., Jalan, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314240 · Cited by 572
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
Llopis, M., Cassard, A. M., Wrzosek, L., Boschat, L., Bruneau, A., Ferrere, G., Puchois, V, Martin, J. C., Lepage, P., Le Roy, T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310585 · Cited by 560
Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment
Liu, Z., Dai, X., Zhang, H., Shi, R., Hui, Y., Jin, X., Zhang, W., Wang, L., Wang, Q., Wang, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14676-4 · Cited by 549
Linkage of gut microbiome with cognition in hepatic encephalopathy
Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00190.2011 · Cited by 547
Self-citationGut microbiome and liver diseases
Tilg, H., Cani, P. D., & Mayer, E. A. (2016) · Gut · doi:10.1136/gutjnl-2016-312729 · Cited by 525
Trebicka, J., Fernandez, J., Papp, M., Caraceni, P., Laleman, W., Gambino, C., Giovo, I., Uschner, F. E., Jimenez, C., Mookerjee, R., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.06.013 · Cited by 525
Self-citationMetabolites: messengers between the microbiota and the immune system
Levy, M., Thaiss, C. A., & Elinav, E. (2016) · Genes & Development · doi:10.1101/gad.284091.116 · Cited by 439
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study
Borzio, M., Salerno, F., Piantoni, L., Cazzaniga, M., Angeli, P., Bissoli, F., Boccia, S., Colloredo-Mels, G., Corigliano, P., Fornaciari, G., et al. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80134-1 · Cited by 438
Acute-on-chronic liver failure in cirrhosis
Arroyo, V., Moreau, R., Kamath, P. S., Jalan, R., Ginès, P., Nevens, F., Fernández, J., To, U., García-Tsao, G., & Schnabl, B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.41 · Cited by 434
Self-citationBacterial translocation of enteric organisms in patients with cirrhosis
Cirera, I., Martin Bauer, T., Navasa, M., Vila, J., Grande, L., Taurá, P., Fuster, J., Garcı́a-Valdecasas, J. C., Lacy, A., Suárez, M. J., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00013-1 · Cited by 432
Bajaj, J. S., Heuman, D. M., Sanyal, A. J., Hylemon, P. B., Sterling, R. K., Stravitz, R. T., Fuchs, M., Ridlon, J. M., Daita, K., Monteith, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060042 · Cited by 430
Navasa, M., Follo, A., Filella, X., Jiménez, W., Francitorra, A., Planas, R., Rimola, A., Arroyo, V., & Rodés, J. (1998) · Hepatology · doi:10.1002/hep.510270507 · Cited by 430
Weingarden, A. R., Chen, C., Bobr, A., Yao, D., Lu, Y., Nelson, V. M., Sadowsky, M. J., & Khoruts, A. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00282.2013 · Cited by 423
FXR: a metabolic regulator and cell protector
Wang, Y.-D., Chen, W.-D., Moore, D. D., & Huang, W. (2008) · Cell Research · doi:10.1038/cr.2008.289 · Cited by 389
Fernández, J., Prado, V., Trebicka, J., Amoros, A., Gustot, T., Wiest, R., Deulofeu, C., Garcia, E., Acevedo, J., Fuhrmann, V., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.027 · Cited by 374
Self-citationChu, H., Duan, Y., Yang, L., & Schnabl, B. (2019) · Gut · doi:10.1136/gutjnl-2018-316307 · Cited by 354
Self-citationPhilips, C. A., Pande, A., Shasthry, S. M., Jamwal, K. D., Khillan, V., Chandel, S. S., Kumar, G., Sharma, M. K., Maiwall, R., Jindal, A., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.029 · Cited by 349
Acute-on-chronic liver failure: terminology, mechanisms and management
Sarin, S. K., & Choudhury, A. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.219 · Cited by 342
Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
Ridlon, J. M., Alves, J. M., Hylemon, P. B., & Bajaj, J. S. (2013) · Gut Microbes · doi:10.4161/gmic.25723 · Cited by 336
Self-citationA Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Oh, T. G., Kim, S. M., Caussy, C., Fu, T., Guo, J., Bassirian, S., Singh, S., Madamba, E. V., Bettencourt, R., Richards, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.005 · Cited by 334
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Heuman, D. M., Daita, K., White, M. B., Unser, A., Thacker, L. R., Sanyal, A. J., Kang, D. J., et al. (2015) · Hepatology · doi:10.1002/hep.27819 · Cited by 325
Self-citationChen, P., Stärkel, P., Turner, J. R., Ho, S. B., & Schnabl, B. (2015) · Hepatology · doi:10.1002/hep.27489 · Cited by 312
Self-citationShi, Y., Yang, Y., Hu, Y., Wu, W., Yang, Q., Zheng, M., Zhang, S., Xu, Z., Wu, Y., Yan, H., et al. (2015) · Hepatology · doi:10.1002/hep.27795 · Cited by 305
Trebicka, J., Fernandez, J., Papp, M., Caraceni, P., Laleman, W., Gambino, C., Giovo, I., Uschner, F. E., Jansen, C., Jimenez, C., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.019 · Cited by 304
Self-citationBajaj, J. S., Salzman, N. H., Acharya, C., Sterling, R. K., White, M. B., Gavis, E. A., Fagan, A., Hayward, M., Holtz, M. L., Matherly, S., et al. (2019) · Hepatology · doi:10.1002/hep.30690 · Cited by 295
Self-citationMichelena, J., Altamirano, J., Abraldes, J. G., Affò, S., Morales‐Ibanez, O., Sancho‐Bru, P., Dominguez, M., García‐Pagán, J. C., Fernández, J., Arroyo, V., et al. (2015) · Hepatology · doi:10.1002/hep.27779 · Cited by 291
Hartmann, P., Hochrath, K., Horvath, A., Chen, P., Seebauer, C. T., Llorente, C., Wang, L., Alnouti, Y., Fouts, D. E., Stärkel, P., et al. (2018) · Hepatology · doi:10.1002/hep.29676 · Cited by 290
Abedon, S., & Thomas-Abedon, C. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725410 · Cited by 284
Xu, D., Gao, J., Gillilland, M., Wu, X., Song, I., Kao, J. Y., & Owyang, C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.026 · Cited by 271
O'Leary, J. G., Reddy, K. R., Garcia‐Tsao, G., Biggins, S. W., Wong, F., Fallon, M. B., Subramanian, R. M., Kamath, P. S., Thuluvath, P., Vargas, H. E., et al. (2018) · Hepatology · doi:10.1002/hep.29773 · Cited by 271
Self-citationBauer, T. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)03230-0 · Cited by 266
A randomized clinical trial of fecal microbiota transplant for alcohol use disorder
Bajaj, J. S., Gavis, E. A., Fagan, A., Wade, J. B., Thacker, L. R., Fuchs, M., Patel, S., Davis, B., Meador, J., Puri, P., et al. (2021) · Hepatology · doi:10.1002/hep.31496 · Cited by 262
Self-citationChang, C.-S., Chen, G.-H., Lien, H.-C., & Yeh, H.-Z. (1998) · Hepatology · doi:10.1002/hep.510280504 · Cited by 261
Sorribas, M., Jakob, M. O., Yilmaz, B., Li, H., Stutz, D., Noser, Y., de Gottardi, A., Moghadamrad, S., Hassan, M., Albillos, A., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.017 · Cited by 253
Weingarden, A., González, A., Vázquez-Baeza, Y., Weiss, S., Humphry, G., Berg-Lyons, D., Knights, D., Unno, T., Bobr, A., Kang, J., et al. (2015) · Microbiome · doi:10.1186/s40168-015-0070-0 · Cited by 248
Lang, S., Duan, Y., Liu, J., Torralba, M. G., Kuelbs, C., Ventura‐Cots, M., Abraldes, J. G., Bosques‐Padilla, F., Verna, E. C., Brown, R. S., et al. (2020) · Hepatology · doi:10.1002/hep.30832 · Cited by 236
Self-citationMucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
Hegde, P., Weiss, E., Paradis, V., Wan, J., Mabire, M., Sukriti, S., Rautou, P.-E., Albuquerque, M., Picq, O., Gupta, A. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04450-y · Cited by 232
The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease
Chu, H., Duan, Y., Lang, S., Jiang, L., Wang, Y., Llorente, C., Liu, J., Mogavero, S., Bosques-Padilla, F., Abraldes, J. G., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.029 · Cited by 228
Self-citationVerbeke, L., Farre, R., Verbinnen, B., Covens, K., Vanuytsel, T., Verhaegen, J., Komuta, M., Roskams, T., Chatterjee, S., Annaert, P., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.10.009 · Cited by 225
Self-citationDysregulation of serum bile acids and FGF19 in alcoholic hepatitis
Brandl, K., Hartmann, P., Jih, L. J., Pizzo, D. P., Argemi, J., Ventura-Cots, M., Coulter, S., Liddle, C., Ling, L., Rossi, S. J., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.031 · Cited by 216
Self-citationAntibiotic prophylaxis in cirrhosis: Good and bad
Fernández, J., Tandon, P., Mensa, J., & Garcia‐Tsao, G. (2016) · Hepatology · doi:10.1002/hep.28330 · Cited by 203
Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice
Mazagova, M., Wang, L., Anfora, A. T., Wissmueller, M., Lesley, S. A., Miyamoto, Y., Eckmann, L., Dhungana, S., Pathmasiri, W., Sumner, S., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-259515 · Cited by 199
Teltschik, Z., Wiest, R., Beisner, J., Nuding, S., Hofmann, C., Schoelmerich, J., Bevins, C. L., Stange, E. F., & Wehkamp, J. (2012) · Hepatology · doi:10.1002/hep.24789 · Cited by 194
Trebicka, J., Amoros, A., Pitarch, C., Titos, E., Alcaraz-Quiles, J., Schierwagen, R., Deulofeu, C., Fernandez-Gomez, J., Piano, S., Caraceni, P., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00476 · Cited by 190
Self-citationColonic inflammation and secondary bile acids in alcoholic cirrhosis
Kakiyama, G., Hylemon, P. B., Zhou, H., Pandak, W. M., Heuman, D. M., Kang, D. J., Takei, H., Nittono, H., Ridlon, J. M., Fuchs, M., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00315.2013 · Cited by 179
Self-citationÚbeda, M., Lario, M., Muñoz, L., Borrero, M.-J., Rodríguez-Serrano, M., Sánchez-Díaz, A.-M., del Campo, R., Lledó, L., Pastor, Ó., García-Bermejo, L., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.12.010 · Cited by 178
A Guide to Diet-Microbiome Study Design
Johnson, A. J., Zheng, J. J., Kang, J. W., Saboe, A., Knights, D., & Zivkovic, A. M. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00079 · Cited by 176
Francés, R., Zapater, P., González-Navajas, J. M., Muñoz, C., Caño, R., Moreu, R., Pascual, S., Bellot, P., Pérez-Mateo, M., & Such, J. (2008) · Hepatology · doi:10.1002/hep.22083 · Cited by 169
Ponziani, F. R., Zocco, M. A., D’Aversa, F., Pompili, M., & Gasbarrini, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4491 · Cited by 168
Bajaj, J. S., Liu, E. J., Kheradman, R., Fagan, A., Heuman, D. M., White, M., Gavis, E. A., Hylemon, P., Sikaroodi, M., & Gillevet, P. M. (2018) · Gut · doi:10.1136/gutjnl-2016-313170 · Cited by 167
Self-citationCirculating microbiome in blood of different circulatory compartments
Schierwagen, R., Silva, M. C. A., Madsen, M. S. A., Kolbe, C. C., Meyer, C. H., Thomas, D., Uschner, F. E., Magdaleno, F., Jansen, C., Pohlmann, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316227 · Cited by 167
Self-citationMicrobiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Bajaj, J. S., & Khoruts, A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.017 · Cited by 167
Self-citationLi, H., Chen, L.-Y., Zhang, N.-N., Li, S.-T., Zeng, B., Pavesi, M., Amorós, À., Mookerjee, R. P., Xia, Q., Xue, F., et al. (2016) · Scientific Reports · doi:10.1038/srep25487 · Cited by 160
Bajaj, J. S., Kakiyama, G., Savidge, T., Takei, H., Kassam, Z., Fagan, A., Gavis, E. A., Pandak, W. M., Nittono, H., Hylemon, P. B., et al. (2018) · Hepatology · doi:10.1002/hep.30037 · Cited by 156
Self-citationTuomisto, S., Pessi, T., Collin, P., Vuento, R., Aittoniemi, J., & Karhunen, P. J. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-40 · Cited by 155
Intestinal Virome in Patients With Alcoholic Hepatitis
Jiang, L., Lang, S., Duan, Y., Zhang, X., Gao, B., Chopyk, J., Schwanemann, L. K., Cots, M. V., Bataller, R. A., Bosques‐Padilla, F., et al. (2020) · Hepatology · doi:10.1002/hep.31459 · Cited by 152
Self-citationReorganisation of Faecal Microbiota Transplant Services During the COVID-19 Pandemic
Ianiro, G., Mullish, B. H., Kelly, C. R., Kassam, Z., Kuijper, E. J., Ng, S. C., Iqbal, T. H., Allegretti, J. R., Bibbò, S., Sokol, H., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321829 · Cited by 147
Muñoz, L., Borrero, M., Cantera, M., Conde, E., del Campo, R., Rodríguez‐Serrano, M., Lario, M., Sánchez‐Díaz, A., Pastor, Ó., Díaz, D., et al. (2018) · Hepatology · doi:10.1002/hep.30349 · Cited by 145
Philips, C. A., Phadke, N. D., Ganesan, K., Ranade, S., & Augustine, P. (2018) · Indian Journal of Gastroenterology · doi:10.1007/s12664-018-0859-4 · Cited by 142
Fecal microbiota transplantation in the management of hepatic encephalopathy
Kao, D. H., Roach, B., Park, H., Hotte, N., Madsen, K. L., Bain, V. G., & Tandon, P. (2015) · Hepatology · doi:10.1002/hep.28121 · Cited by 139
Solé, C., Solà, E., Morales‐Ruiz, M., Fernández, G., Huelin, P., Graupera, I., Moreira, R., de Prada, G., Ariza, X., Pose, E., et al. (2016) · Scientific Reports · doi:10.1038/srep32341 · Cited by 138
Grønbæk, H., Rødgaard‐Hansen, S., Aagaard, N. K., Arroyo, V., Moestrup, S. K., García, E., Solà, E., Domenicali, M., Piano, S. S., Vilstrup, H., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.021 · Cited by 136
Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis
Bajaj, J. S., Matin, P., White, M. B., Fagan, A., Deeb, J. G., Acharya, C., Dalmet, S. S., Sikaroodi, M., Gillevet, P. M., & Sahingur, S. E. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00230.2018 · Cited by 135
Self-citationAddolorato, G., Ponziani, F. R., Dionisi, T., Mosoni, C., Vassallo, G. A., Sestito, L., Petito, V., Picca, A., Marzetti, E., Tarli, C., et al. (2020) · Liver International · doi:10.1111/liv.14383 · Cited by 135
Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort
Bajaj, J. S., Reddy, K. R., Tandon, P., Wong, F. S.-H., Kamath, P. S., Biggins, S. W., García–Tsao, G., Fallon, M. B., Maliakkal, B. J., Lai, J. C., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.471 · Cited by 132
Self-citationBajaj, J. S., Acharya, C., Fagan, A., White, M. B., Gavis, E. A., Heuman, D. M., Hylemon, P. B., Fuchs, M. A., Puri, P., Schubert, M. L., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0085-9 · Cited by 127
Self-citationBajaj, J. S., Vargas, H. E., Reddy, K. R., Lai, J. C., O’Leary, J. G., Tandon, P., Wong, F. S.-H., Mitrani, R., White, M. B., Kelly, M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.022 · Cited by 127
Self-citationDonor Screening for Fecal Microbiota Transplantation
Kassam, Z., Dubois, N. E., Ramakrishna, B., Ling, K., Qazi, T., Smith, M. B., Kelly, C. R., Fischer, M., Allegretti, J. R., Budree, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1913670 · Cited by 127
Bajaj, J. S., Idilman, R., Mabudian, L., Hood, M., Fagan, A., Turan, D., White, M. B., Karakaya, F., Wang, J., Atalay, R., et al. (2018) · Hepatology · doi:10.1002/hep.29791 · Cited by 125
Self-citationBajaj, J. S., Reddy, K. R., O’Leary, J. G., Vargas, H. E., Lai, J. C., Kamath, P. S., Tandon, P., Wong, F. S.-H., Subramanian, R., Thuluvath, P. J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.019 · Cited by 125
Self-citationYe, F., Shen, H., Li, Z., Meng, F., Li, L., Yang, J., Chen, Y., Bo, X., Zhang, X., & Ni, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150519 · Cited by 113
Mencarelli, A., Migliorati, M., Barbanti, M., Cipriani, S., Palladino, G., Distrutti, E., Renga, B., & Fiorucci, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.022 · Cited by 109
Liu, R., Kang, J. D., Sartor, R. B., Sikaroodi, M., Fagan, A., Gavis, E. A., Zhou, H., Hylemon, P. B., Herzog, J., Li, X., et al. (2019) · Hepatology · doi:10.1002/hep.30827 · Cited by 109
Self-citationEffect of Lactitol and Lactulose Administration on the Fecal Flora in Cirrhotic Patients
Riggio, O., Varriale, M., Testore, G. P., Rosa, R. D., Rosa, E. D., Merli, M., Romiti, A., Candiani, C., & Capocaccia, L. (1990) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199008000-00016 · Cited by 108
Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
Kang, D. J., Kakiyama, G., Betrapally, N. S., Herzog, J., Nittono, H., Hylemon, P. B., Zhou, H., Carroll, I. M., Yang, J., Gillevet, P. M., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.44 · Cited by 105
Self-citationA longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy
Bajaj, J. S., Gillevet, P. M., Patel, N. R., Ahluwalia, V., Ridlon, J. M., Kettenmann, B., Schubert, C. M., Sikaroodi, M., Heuman, D. M., Crossey, M. M. E., et al. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9303-0 · Cited by 104
Self-citationLiver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis
Bajaj, J. S., Fagan, A., Sikaroodi, M., White, M. B., Sterling, R. K., Gilles, H., Heuman, D. M., Stravitz, R. T., Matherly, S. C., Siddiqui, M. S., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24754 · Cited by 103
Self-citationDecompensated cirrhosis and microbiome interpretation
Bajaj, J. S., Betrapally, N. S., & Gillevet, P. M. (2015) · Nature · doi:10.1038/nature14851 · Cited by 100
Self-citationInteraction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy
Bajaj, J. S., Sikaroodi, M., Shamsaddini, A., Henseler, Z. M., Santiago-Rodríguez, T. M., Acharya, C., Fagan, A., Hylemon, P. B., Fuchs, M. A., Gavis, E. A., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322470 · Cited by 99
Self-citationMonteiro, S. B., Grandt, J., Uschner, F. E., Kimer, N., Madsen, J. L., Schierwagen, R., Klein, S., Welsch, C., Schaefer, L., Jansen, C., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320170 · Cited by 97
Self-citationBajaj, J. S., Salzman, N. H., Acharya, C., Takei, H., Kakiyama, G., Fagan, A., White, M. B., Gavis, E. A., Holtz, M. L., Hayward, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.133410 · Cited by 94
Self-citationHorvath, A., Rainer, F., Bashir, M., Leber, B., Schmerboeck, B., Klymiuk, I., Groselj-Strele, A., Durdevic, M., Freedberg, D. E., Abrams, J. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48352-5 · Cited by 93
Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study
Shao, L., Ling, Z., Chen, D., Liu, Y., Yang, F., & Li, L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03166 · Cited by 92
Goel, A., Rahim, U. G., Nguyen, L. H., Stave, C. D., & Nguyen, M. H. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14361 · Cited by 89
Effects of Rifaximin Administration on the Intestinal Microbiota in Patients with Ulcerative Colitis
Brigidi, P., Swennen, E., Rizzello, F., Bozzolasco, M., & Matteuzzi, D. (2002) · Journal of Chemotherapy · doi:10.1179/joc.2002.14.3.290 · Cited by 88
Bosoi, C. R., Parent-Robitaille, C., Anderson, K. E., Tremblay, M., & Rose, C. F. (2011) · Hepatology · doi:10.1002/hep.24273 · Cited by 88
Ponziani, F. R., Putignani, L., Sterbini, F. P., Petito, V., Picca, A., CHIERICO, F. D., Reddel, S., Calvani, R., Marzetti, E., Sanguinetti, M., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15004 · Cited by 88
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Oh, T. G., Kim, S. M., Caussy, C., Fu, T., Guo, J. P., Bassirian, S., Singh, S., Madamba, E. V., Bettencourt, R., Richards, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.015 · Cited by 83
Zhai, S., Zhu, L., Qin, S., & Li, L. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.612 · Cited by 80
Fuchs, C. D., Paumgartner, G., Mlitz, V., Kunczer, V., Halilbasic, E., Leditznig, N., Wahlström, A., Ståhlman, M., Thüringer, A., Kashofer, K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314553 · Cited by 76
Muñoz, L., Borrero, M. J., Cantera, M., Lario, M., Díaz, D., Francés, R., Monserrat, J., Pastor, Ó., Aguado-Fraile, E., Such, J. M., et al. (2012) · Hepatology · doi:10.1002/hep.25854 · Cited by 75
Alteration of the serum microbiome composition in cirrhotic patients with ascites
Santiago, A., Pozuelo, M., Poca, M., Gely, C., Nieto, J. C., Torras, X., Román, E. M., Campos, D., Sarrabayrouse, G., Vidal, S., et al. (2016) · Scientific Reports · doi:10.1038/srep25001 · Cited by 72
Kimer, N., Pedersen, J. S., Tavenier, J., Christensen, J. E., Busk, T. M., Hobolth, L., Krag, A. A., Al‐Soud, W. A., Mortensen, M. S., Sørensen, S. J., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13852 · Cited by 70
Cheng, Y., Phelps, E. L., Nemes, S., Rogers, N. A., Sagi, S. V., Bohm, M. E., El-Halabi, M. M., Allegretti, J. R., Kassam, Z., Xu, H., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.12.029 · Cited by 69
Takahashi, S., Luo, Y., Ranjit, S., Xie, C., Libby, A. E., Orlicky, D. J., Dvornikov, A. S., Wang, X. X., Myakala, K., Jones, B. A., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011913 · Cited by 67
Praktiknjo, M., Monteiro, S. B., Grandt, J., Kimer, N., Madsen, J. L., Werge, M. P., William, P., Brol, M. J., Turco, L., Schierwagen, R., et al. (2020) · Liver International · doi:10.1111/liv.14433 · Cited by 65
Self-citationGut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure
Trebicka, J., Reiberger, T., & Laleman, W. (2018) · Visceral Medicine · doi:10.1159/000490262 · Cited by 63
Self-citationChae, J. P., Pajarillo, E. A. B., Oh, J. K., Kim, H., & Kang, D. (2016) · Microbial Biotechnology · doi:10.1111/1751-7915.12370 · Cited by 62
Salehi, S., Tranah, T. H., Lim, S., Heaton, N. D., Heneghan, M. A., Aluvihare, V. R., Patel, V., & Shawcross, D. L. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15326 · Cited by 62
Self-citationKalambokis, G. N., & Tsianos, E. V. (2011) · Hepatology · doi:10.1002/hep.24751 · Cited by 61
Cheng, Y., Alhaffar, D., Saha, S., Khanna, S., Bohm, M. E., Phelps, E. L., Ghabril, M., Orman, E. S., Sagi, S. V., Rogers, N. A., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.051 · Cited by 61
A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption.
Shindo, K., MACHIDA, M., Miyakawa, K., & Fukumura, M. (1993) · PubMed · Cited by 59
Ziada, D. H., Soliman, H. H., Yamany, S. A. E., Hamisa, M. F., & Hasan, A. (2013) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2013.08.002 · Cited by 58
Zhang, Y., Zhao, R., Shi, D., Sun, S., Ren, H., Zhao, H., Wu, W., Jin, L., Sheng, J., & Shi, Y. (2019) · Liver International · doi:10.1111/liv.14097 · Cited by 58
Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
Sarangi, A. N., Goel, A., Singh, A., Sasi, A., & Aggarwal, R. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0683-9 · Cited by 56
The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin‐α
Orr, J. G., Currie, C. J., Berni, E. R., Goel, A., Moriarty, K. J., Sinha, A., Gordon, F. H., Dethier, A., Dillon, J. F., Clark, K. A. J., et al. (2016) · Liver International · doi:10.1111/liv.13111 · Cited by 54
Self-citationSerum and intestinal secretory IgA in alcoholic cirrhosis of the liver.
Pelletier, G., Briantais, M. J., Buffet, C., et al. (1982) · Gut · doi:10.1136/gut.23.6.475 · Cited by 51
Zacharias, H. D., Zacharias, A. P., Gluud, L. L., & Morgan, M. Y. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012334.pub2 · Cited by 50
Mehta, R. M., Kabrawala, M. V., Nandwani, S. K., Kalra, P., Patel, C. N., Desai, P. N., & Parekh, K. K. (2018) · Indian Journal of Gastroenterology · doi:10.1007/s12664-018-0906-1 · Cited by 49
Gut microbial composition can differentially regulate bile acid synthesis in humanized mice
Kang, D. J., Hylemon, P. B., Gillevet, P. M., Sartor, R. B., Betrapally, N. S., Kakiyama, G., Sikaroodi, M., Takei, H., Nittono, H., Zhou, H., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1020 · Cited by 40
Self-citationActivation-Dependent Adsorption of Cytokines and Toxins Related to Liver Failure to Carbon Beads
Tripisciano, C., Kozynchenko, O. P., Linsberger, I., Phillips, G. J., Howell, C. A., Sandeman, S. R., Tennison, S., Mikhalovsky, S. V., Weber, V., & Falkenhagen, D. (2011) · Biomacromolecules · doi:10.1021/bm200982g · Cited by 33
Pringle, P. L., Soto, M. T., Chung, R. T., & Hohmann, E. L. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.038 · Cited by 30
Ito, T., Nakamura, K., Kageyama, S., Korayem, I. M., Hirao, H., Kadono, K., Aziz, J. M., Younan, S., DiNorcia, J., Agopian, V. G., et al. (2019) · Liver Transplantation · doi:10.1002/lt.25633 · Cited by 29
Saboo, K., Shamsaddini, A., Iyer, M. V., Hu, C., Fagan, A., Gavis, E. A., White, M. B., Fuchs, M. A., Heuman, D. M., Sikaroodi, M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.06.046 · Cited by 29
Self-citationEmergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients
Chang, J. Y., Kim, S., Kim, T. H., Woo, S., Ryu, M. S., Joo, Y.-H., Lee, K. E., Lee, J., Lee, K. H., Moon, C. M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186120 · Cited by 27
Tsuji, Y., Kaji, K., Kitade, M., Kaya, D., Kitagawa, K., Ozutsumi, T., Fujinaga, Y., Takaya, H., Kawaratani, H., Namisaki, T., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8060925 · Cited by 25
Does low‐dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study
Zeng, X., Tang, X., Sheng, X., Ni, W., Xin, H. G., Chen, W. Z., Jiang, C., Lin, Y., Shi, J. G., Shi, B., et al. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12294 · Cited by 23
Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome
Ibrahim, E.-S., Alsebaey, A., Zaghla, H., Abdelmageed, S. M., Gamel, K. A. E. M., & Abdelsameea, E. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000967 · Cited by 22
Meighani, A., Alimirah, M., Ramesh, M. S., & Salgia, R. J. (2020) · International Journal of Hepatology · doi:10.1155/2020/1874570 · Cited by 21
Macnaughtan, J., Ranchal, I., Soeda, J., Sawhney, R., Oben, J. A., Davies, N. A., Mookerjee, R. P., Marchesi, J. R., Cox, J., & Jalan, R. (2015) · Journal of Hepatology · doi:10.1016/s0168-8278(15)30110-0 · Cited by 20
Self-citationFerreira, M. D. F., Schmitz, S. S., Schoenebeck, J. J., Clements, D. N., Campbell, S. M., Gaylor, D., Mellanby, R. J., Gow, A. G., & Salavati, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-50090-7 · Cited by 15
Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis
Hatton, G. B., Ran, S., Tranah, T. H., & Shawcross, D. L. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00520-2 · Cited by 6
Self-citation
Cited by
Gut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
The gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737
Self-citationGut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 287
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Metadata
- Authors
- Trebicka, J., Macnaughtan, J., Schnabl, B., Shawcross, D. L., & Bajaj, J. S.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 75
- Pages
- S67-S81
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3165508634
- Cited by
- 268
- References
- 150
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.